CSBR
CSBR
NASDAQ · Life Sciences Tools & Services

Champions Oncology Inc

$5.84
+0.10 (+1.74%)
As of Mar 30, 10:10 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +404.3% upside
Low Target $20.89
Average Target $29.45
High Target $33.06
Current Price $5.84
Current
$5.84
Target
$29.45
$20.89 $29.45 avg $33.06
Scenario Analysis
Bear Case
$20.89
257.7%
Low target
Base Case
$29.45
+404.3%
Avg target
Bull Case
$33.06
+466.1%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$9.97
-41.4% from high
52-Week Low
$5.50
+6.2% from low
Target vs 52W High
$29.45
+195.3% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 33 88% $369.21 -25.3%
DHR
Danaher Corp
Strong Buy 30 87% $158.11 -17.1%
A
Agilent Technologies Inc
Buy 29 72% $64.69 -43.5%
IQV
Iqvia Holdings Inc
Strong Buy 30 80% $82.96 -51.9%
MTD
Mettler-Toledo International
Hold 21 43% $170.43 -86.6%
ILMN
Illumina Inc
Hold 28 54% $169.36 +33.7%
WAT
Waters Corp
Buy 28 57% $189.60 -36.8%
WST
West Pharmaceutical Services
Strong Buy 23 78% $136.24 -46.1%